Status:
COMPLETED
Rapid Diagnosis of COVID-19 by Chemical Analysis of Exhaled Air
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Covid19
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
Since the start of 2020, the new SARS-CoV-2 coronavirus is causing a real global health crisis. In France, nasopharyngeal swabs are used to obtain the sample needed for respiratory infection screenin...
Eligibility Criteria
Inclusion
- Symptomatic and asymptomatic outpatient without hospitalisation criteria
- No medical contraindications to nasopharyngeal swabbing (deviation of the nasal septum, epistaxis, anticoagulant treatment).
- Patient able to blow into the test device
- Patients or parents with parental authority who have been informed of the study and have not objected to participating in it
Exclusion
- Major subject under guardianship or curatorship or unable to consent to study.
- Subject under safeguard of justice
- Minor patient (age \< 6 years).
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 21 2021
Estimated Enrollment :
4600 Patients enrolled
Trial Details
Trial ID
NCT04706039
Start Date
March 1 2021
End Date
May 21 2021
Last Update
June 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de prélèvement COVID-19 HCL et Métropole de Lyon
Lyon, France, 69000